G. Skretting et al., SODIUM-BUTYRATE INHIBITS THE EXPRESSION OF THE HUMAN LECITHIN - CHOLESTEROL ACYLTRANSFERASE GENE IN HEPG2 CELLS BY A POSTTRANSCRIPTIONAL MECHANISM, FEBS letters, 404(1), 1997, pp. 105-110
We have previously demonstrated that LCAT is downregulated by TGF-beta
and that the regulation is posttranscriptional and involves an increa
sed rate of RNA degradation. Sodium butyrate affects the expression of
several liver-specific genes including some whose levels are altered
during an acute-phase response. We have investigated the effect of sod
ium butyrate on LCAT activity and mRNA levels in HepG2 cells. Both the
LCAT mRNA level and activity were reduced in a dose- and time-depende
nt manner. The reduction of LCAT mRNA levels was not, however, due to
an increased degradation of processed mRNA. The transcriptional activi
ty of the LCAT gene as seen in run-on experiments was not affected by
sodium butyrate, whereas the total level of LCAT transcripts was reduc
ed. Thus, LCAT activity and mRNA level in HepG2 cells are decreased by
sodium butyrate treatment by a post-transcriptional mechanism, most l
ikely involving increased degradation of pre-mRNA. (C) 1997 Federation
of European Biochemical Societies.